| Record ID | harvard_bibliographic_metadata/ab.bib.12.20150123.full.mrc:113125033:2352 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.12.20150123.full.mrc:113125033:2352?format=raw |
LEADER: 02352nam a2200433Ia 4500
001 012098073-8
005 20100518190246.0
008 090916s2008 onca bs f000 0 eng d
020 $a9780662055822
020 $a0662055829
035 0 $aocn436870774
037 $aCL0177200808$bProQuest, 789 E. Eisenhower Parkway, Ann Arbor, MI 48108-3218
040 $aUMI$cUMI
043 $an-cn---
086 1 $aH78-2007
090 $aHD9665.4
110 1 $aCanada.$bPatented Medicine Prices Review Board.
245 10 $aAnnual report 2007 /$cPatented Medicine Prices Review Board.
246 17 $aPMPRB annual report 2007
260 $a[Ottawa] :$bPatented Medicine Prices Review Board,$c[2008]
300 $avi, 62 p. :$bcol. ill. ;$c22 x 28 cm.
500 $aCover title.
500 $aFrench ed. on the same fiche.
530 $aAvailable also on the World Wide Web.
520 3 $aThe Patented Medicine Prices Review Board (PMPRB) is an independent quasi-judicial body established by Parliament in 1987 under the Patent Act (Act). It operates independently of other bodies such as Health Canada, which approves drugs for safety and efficacy, and public drug plans, which approve the listing of drugs on their respective formularies for reimbursement purposes. This document is the annual report of the PMPRB for the year ended December 31, 2007. The report provides detailed information on sales and price trends of medicines in Canada, including internaitonal comparisons; patentees' compliance with the Board's Excessive Price Guidelines; enforcement activities and hearings; and patentees' R & D spending.--Includes text from the publisher's website.
501 $aWith (on inverted pages): Rapport annuel 2007 / Conseil d'examen du prix des médicaments brevetés. [Ottawa] : Conseil d'examen du prix des médicaments brevetés, [2008].
651 2 $aCanada.
650 22 $aDrug and Narcotic Control.
650 22 $aDrug Costs.
650 12 $aPatents as Topic$xstatistics & numerical data.
650 12 $aPharmaceutical Preparations.
610 10 $aCanada.$bPatented Medicine Prices Review Board.
610 10 $aCanada.$tPatent Act.
650 0 $aDrugs$xPrices$zCanada.
650 0 $aPatents$zCanada$vStatistics.
650 0 $aPharmaceutical policy$zCanada.
650 0 $aPharmacy$xResearch$zCanada.
988 $a20091015
906 $0OCLC